Andrea Lapucci

2.1k total citations
54 papers, 1.7k citations indexed

About

Andrea Lapucci is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Andrea Lapucci has authored 54 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 20 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Andrea Lapucci's work include Cell death mechanisms and regulation (7 papers), PARP inhibition in cancer therapy (7 papers) and Mitochondrial Function and Pathology (6 papers). Andrea Lapucci is often cited by papers focused on Cell death mechanisms and regulation (7 papers), PARP inhibition in cancer therapy (7 papers) and Mitochondrial Function and Pathology (6 papers). Andrea Lapucci collaborates with scholars based in Italy, United States and Qatar. Andrea Lapucci's co-authors include Alberto Chiarugi, S. Capaccioli, Martino Donnini, Nicola Schiavone, Laura Papucci, Ewa Witort, Roberta Felici, Alessio Tempestini, A Nicolin and Lucia Formigli and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Andrea Lapucci

54 papers receiving 1.7k citations

Peers

Andrea Lapucci
Comparison fields: 5 of 107
  • Molecular Biology 1.1k
  • Oncology 378
  • Geriatrics and Gerontology 198
  • Cancer Research 196
  • Physiology 172
Christine Loh United States
Laura Formentini Spain
Junlian Gu China
Xinqun Li United States
Si‐Chi Xu China
Jinling Hou United States
Cristina Travelli Italy
Roberta Felici Italy
Rebecca S. Keller United States
Elena Rapizzi Italy
Christine Loh United States View profile →
Citations per field, relative to Andrea Lapucci
Andrea Lapucci · 1×
Citations per year, relative to Andrea Lapucci
Andrea Lapucci · 1×

Countries citing papers authored by Andrea Lapucci

Since Specialization
Citations

This map shows the geographic impact of Andrea Lapucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Lapucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Lapucci more than expected).

Fields of papers citing papers by Andrea Lapucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Lapucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Lapucci. The network helps show where Andrea Lapucci may publish in the future.

Co-authorship network of co-authors of Andrea Lapucci

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Lapucci. A scholar is included among the top collaborators of Andrea Lapucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Lapucci. Andrea Lapucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Unveiling the Role of Tryptophan 2,3-Dioxygenase in the Angiogenic Process Pharmaceuticals Maria Luisa Coniglio, Aurora Chinnici et al. 3
2 Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells Frontiers in Pharmacology Matteo Lulli, Andrea Trabocchi et al. 1
3 Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth Pharmacological Research Sara Pepe, Giuseppe Giannini et al. 16
4 Establishment and characterization of a new spontaneously immortalized ER−/PR−/HER2+ human breast cancer cell line, DHSF-BR16 Scientific Reports Stefania Nobili, Antonella Mannini et al. 1
5 Post onset, oral rapamycin treatment delays development of mitochondrial encephalopathy only at supramaximal doses Neuropharmacology Roberta Felici, Daniela Buonvicino et al. 22
6 Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation Neuropharmacology Lorenzo Di Cesare Mannelli, Barbara Tenci et al. 39
7 High-dose methadone: Management of an opioid-addicted patient Florence Research (University of Florence) Andrea Lapucci, Emanuela Masini et al. 1
8 Pharmacological NAD-Boosting Strategies Improve Mitochondrial Homeostasis in Human Complex I–Mutant Fibroblasts Molecular Pharmacology Roberta Felici, Andrea Lapucci et al. 22
9 PARP Inhibition Delays Progression of Mitochondrial Encephalopathy in Mice Neurotherapeutics Roberta Felici, Leonardo Cavone et al. 27
10 Insight into Molecular and Functional Properties of NMNAT3 Reveals New Hints of NAD Homeostasis within Human Mitochondria PLoS ONE Roberta Felici, Andrea Lapucci et al. 48
11 Poly(ADP-ribose) Polymerase-1 Is a Nuclear Epigenetic Regulator of Mitochondrial DNA Repair and Transcription Molecular Pharmacology Andrea Lapucci, Maria Gloria Pittelli et al. 56
12 Inhibition of Nicotinamide Phosphoribosyltransferase Journal of Biological Chemistry Maria Gloria Pittelli, Laura Formentini et al. 155
13 Systemic Sclerosis-Endothelial Cell Antiangiogenic Pentraxin 3 and Matrix Metalloprotease 12 Control Human Breast Cancer Tumor Vascularization and Development in Mice Neoplasia Francesca Margheri, Simona Serratì et al. 31
14 Autologous Lipofilling: Coenzyme Q10 Can Rescue Adipocytes from Stress-Induced Apoptotic Death Plastic & Reconstructive Surgery Ewa Witort, Laura Papucci et al. 21
15 Impact of Targeting the Adenine- and Uracil-Rich Element of bcl-2 mRNA with Oligoribonucleotides on Apoptosis, Cell Cycle, and Neuronal Differentiation in SHSY-5Y Cells Molecular Pharmacology Laura Papucci, Ewa Witort et al. 4
16 Apoptosis shifts to necrosis via intermediate types of cell death by a mechanism depending on c- myc and bcl-2 expression Cell and Tissue Research Laura Papucci, Lucia Formigli et al. 32
17 Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozyme Cancer Gene Therapy Ettore Luzi, Laura Papucci et al. 21
18 Phosphodiester Oligonucleotides Inhibit Mitosis and Trigger Apoptosis by a Non-Antisense, p53-Mediated Mechanism Antisense and Nucleic Acid Drug Development Laura Papucci, Nicola Schiavone et al. 8
19 Apoptosis Is Associated with Modifications of bcl-2 mRNA AU-Binding Proteins Biochemical and Biophysical Research Communications Martino Donnini, Andrea Lapucci et al. 19
20 Induction of Apoptosis and Mitosis Inhibition by Degraded DNA Lipotransfection Mimicking Genotoxic Drug Effects Biochemical and Biophysical Research Communications Nicola Schiavone, Laura Papucci et al. 11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026